| __timestamp | Neurocrine Biosciences, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 46425000 | 22223073 |
| Thursday, January 1, 2015 | 81491000 | 6966842 |
| Friday, January 1, 2016 | 94291000 | 9000499 |
| Sunday, January 1, 2017 | 121827000 | 13741186 |
| Monday, January 1, 2018 | 160524000 | 19040000 |
| Tuesday, January 1, 2019 | 200000000 | 23559000 |
| Wednesday, January 1, 2020 | 275000000 | 31931000 |
| Friday, January 1, 2021 | 328100000 | 44981000 |
| Saturday, January 1, 2022 | 463800000 | 54234000 |
| Sunday, January 1, 2023 | 565000000 | 63806000 |
| Monday, January 1, 2024 | 731100000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
Neurocrine Biosciences has shown a remarkable increase in R&D expenses, growing by over 1,100% from 2014 to 2023. This surge underscores their aggressive pursuit of new therapies and treatments, positioning them as a leader in the biotech sector.
In contrast, Viking Therapeutics has maintained a more modest growth in R&D spending, with a 187% increase over the same period. While their investment is smaller, it reflects a strategic focus on targeted innovations.
This data highlights the diverse strategies within the biotech industry, where both aggressive and measured approaches can lead to success.
Comparing Innovation Spending: Amgen Inc. and Neurocrine Biosciences, Inc.
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Alkermes plc
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Neurocrine Biosciences, Inc. and CRISPR Therapeutics AG Allocate Funds
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Neurocrine Biosciences, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.